Thursday, 9 October 2025

What Makes Farmson a Leader in Paracetamol DC Granules Manufacturing

What Makes Farmson a Leader in Paracetamol DC Granules Manufacturing

Farmson Basic Drugs leads in Paracetamol DC Granules manufacturing with an EU GMP-certified facility, 3600 MTPA capacity, and advanced GLATT technology. Our granules ensure superior flowability, compressibility, and pharmacopeial compliance (EP/BP/USP/IP). Supported by in-house FR&D innovation, scalable production, and customized packaging, Farmson delivers consistent, high-quality grades like DC 97%, 96%, 90%, and 83.3%. With vertical integration and decades of expertise, we set global standards in Paracetamol DC excellence.


For More Information Visit:
https://www.farmson.com/blogs/what-makes-farmson-a-leader-in-paracetamol-dc-granules-manufacturing/

No comments:

Post a Comment

Research & Development - Driving Innovation at Farmson

Research & Development is the engine behind Farmson’s long-term success in pharmaceutical manufacturing. With a dedicated, state-of-the-...